Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02678091
Other study ID # ALR_2015_40
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 30, 2016
Est. completion date June 2023

Study information

Verified date December 2023
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Orbital masses develop at the expense of the orbital structures lacrimal glands, oculomotor muscles, optic nerve, meningeal spaces, peripheral nerves, bone wall, orbital fat, lymphoid structures or vascular structures. These masses can be tumors, benign or malignant, or pseudotumor, mainly represented by specific or non-specific orbital inflammation. Pathology is of considerable importance for the diagnosis and the treatment of those masses. However, biopsy or surgical resection of the orbital masses is sometimes difficult and dangerous outside expert centers. The identification of a non-invasive technique for distinguishing tumors from pseudotumors, thus avoid in some cases a biopsy, would be a major contribution for the patients. Quantitative analysis of the ultrasound exam with doppler of those masses could identify diagnostic criteria, especially for the lacrimal gland, easily explorable.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patient aged 18 years or more - with an orbital mass for which a biopsy and/or a surgical removal is planned - before surgery or biopsy Exclusion Criteria: - pregnancy - breast feeding - patient under a legal protection procedure - patient denying to participate to the study - lack of affiliation to a social security system

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ultrasound exam with Doppler
Ultrasound exam of the orbit

Locations

Country Name City State
France Fondation ophtalmique Adolphe de Rothschild Paris

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity, expressed as a percentage, of the ultrasound exam with Doppler, the pathological exam being the gold standard One month
Primary Specificity, expressed as a percentage, of the ultrasound exam with Doppler, the pathological exam being the gold standard One month